Deng, PhD, Xiaobing, Jian-Jun Wei, MD, and Shengle Zhang, MD. “Screening Genetic Alterations of Biomarkers BRAF, ROS-1, and HER2 by Immunohistochemistry in Ovarian Carcinomas for Targeted Therapy”. North American Journal of Medicine and Science 10, no. 2 (April 30, 2017). Accessed May 12, 2026. https://najms.com/index.php/najms/article/view/334.